Skip to content

Drug interactions

Erdafitinib + Gemfibrozil

Severity: Moderate

Erdafitinib and Gemfibrozil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib is cleared mainly by CYP2C9 and CYP3A4, and gemfibrozil inhibits CYP2C9 along with CYP2C8. Erdafitinib exposure may increase, raising the risk of hyperphosphatemia, ocular toxicity and stomatitis.

What this interaction means in plain words

Erdafitinib and Gemfibrozil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Gemfibrozil belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Gemfibrozil inhibits CYP2C9-mediated metabolism of erdafitinib.

What to do

Prefer a different lipid-lowering agent. If coadministration is needed, monitor closely for adverse reactions and reduce the erdafitinib dose as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Gemfibrozil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Gemfibrozil?

MediHelp rates the interaction as moderate. Erdafitinib and Gemfibrozil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib is cleared mainly by CYP2C9 and CYP3A4, and gemfibrozil inhibits CYP2C9 along with CYP2C8. Erdafitinib exposure may increase, raising the risk of hyperphosphatemia, ocular toxicity and stomatitis.

How serious is the interaction between Erdafitinib and Gemfibrozil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a different lipid-lowering agent. If coadministration is needed, monitor closely for adverse reactions and reduce the erdafitinib dose as needed.

What other medicines interact with Gemfibrozil?

MediHelp also lists interactions of Gemfibrozil with, for example, Daprodustat, Elagolix, Mavacamten. The full list is on the Gemfibrozil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in